Skin Cancer An Issue Of Oncology Clinics

The cancer that arises from the skin is termed as skin cancer. It occurs due to the development of abnormal cells which can invade or spread to other parts of the body. Melanoma, basal-cell skin cancer and squamous-cell skin cancer are the primary types of skin cancers. Basal-cell carcinomas are those that appear on the sun-exposed areas of the skin, particularly the face. They rarely metastasize and are easily treated with radiation or surgery. Squamous-cell skin cancer metastasizes. Melanomas are the rarest of all skin cancers but frequently metastasize. They can potentially cause death once they spread. Ulcering of the skin, changes in existing moles, patch on skin, enlargement of mole, etc. are some of the signs of skin cancer. It can be diagnosed through a biopsy, histopathological examination, dermoscopy, sonography, etc. The treatment of skin cancer is determined by an assessment of the location of the tumor, specific type of cancer, age and whether it is a primary cancer or a recurrence. Melanomas usually respond poorly to radiation or chemotherapy. Radiation therapy, topical chemotherapy, cryotherapy, electrodesiccation and curettage, photodynamic therapy, Mohs surgery, etc. are some of the strategies in the treatment of skin cancer. This book includes some of the vital pieces of work being conducted across the world, on various topics related to skin cancer. It brings forth some of the most innovative concepts and elucidates the unexplored aspects of oncology. It aims to equip students and experts with the advanced topics and upcoming concepts in this domain.

This issue of Hematology/Oncology Clinics, Guest Edited by F. Stephen Hodi, is devoted to Melanoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: State of Melanoma, Biology of Melanoma, Epidemiology of Melanoma, Surgical Management of Melanoma, Melanoma Adjuvant Therapy, Targeted Therapies for Melanoma, Non-cutaneous Melanomas, Immune Checkpoint Therapies for Melanoma, Resistance Mechanisms to Current Therapies, Cellular Therapy and Cytokine Treatments for Melanoma, Combinatorial Approaches to the Treatment of Melanoma, and Melanoma Future Directions.

This issue of Dermatologic Clinics, guest edited by Dr. Lindsay C. Strowd of Wake Forest Baptist Health, is devoted to the Intersection of Dermatology and Oncology. This issue focuses on Melanoma, Nonmelanoma Skin Cancer, Cutaneous Lymphoma, Other Cutaneous Malignancies, Special Topics in Skin Cancer Diagnosis and Treatment, Dermatology in the Diagnosis of Non-cutaneous Malignancy, Dermatology in the Management of Non-cutaneous Malignancy, and Genodermatoses with Neoplastic Behavior. Articles in this issue include: Update on current treatment recommendations for primary cutaneous melanoma; Nonsurgical treatments for advanced melanoma; Update on current treatment recommendations for NMSC; Nonsurgical treatments for NMSC; Diagnosis and management of CBCL; Diagnosis and management of CTCL; Lymphomatoid papulosis and other lymphoma-like diseases (PLC, PLEVA, CD30+ disease); Dermatofibrosarcoma protuberans updates; Merkel cell carcinoma updates; Kaposi sarcoma updates; Skin cancer in skin of color patients; Skin cancer detection technology; Paraneoplastic diseases; Cutaneous metastases of internal tumors; Cutaneous side effects of chemotherapy agents; GVHD treatment updates; Phakomatoses (NF, TS); and Hereditary tumor syndromes with skin involvement (Gorlins, Lynch, XP, etc.).

This issue of Hematology/Oncology Clinics, guest edited by Drs. Nicole R. LeBoeuf and Cecilia Larocca, with consulting editors George Canellos and Franklin Bunn, will focus on Cutaneous Malignancy. Topics include, but are not limited to, Squamous Cell Carcinoma, Basal Cell Carcinoma, Melanoma, Malignant Neuroendocrine Tumors, Mycosis Fungoides/Sezary Syndrome, CD30+ lymphoproliferative Disorders, Rare Cutaneous T Cell Lymphoma, Cutaneous Involvement of Hematologic Malignancies, Cutaneous B Cell Lymphoma, Adnexal Tumors, Extramammary Paget’s Disease, Cutaneous sarcomas, and Cutaneous metastases.

This issue of Surgical Oncology Clinics, guest edited by Dr. Roshni Dasgupta, is devoted to Pediatric Cancer. Dr. Dasgupta has assembled expert authors to review the following topics: Management of Neuroendocrine Cancer and GIST in Pediatric Patients; Management of Thyroid Tumors in Pediatric Patients; Management of Liver Tumors in Pediatric Patients; Management of Renal Tumors in Pediatric Patients; Management of Rhabdomyosarcoma in Pediatric Patients; Management of non-Rhabdomyosarcoma Soft Tissues Tumors in Pediatric Patients; Management of Melanoma and Skin Cancer in Pediatric Patients; Management of Lung Metastases in Pediatric Patients; Management of Adrenal Tumors in Pediatric Patients; Minimally Invasive Surgery and New Techniques in Pediatric Cancer Patients; Fertility Considerations and the Pediatric Cancer Patient; Management of Neuroblastoma in Pediatric Patients; Management of Germ Cell Tumors in Pediatric Patients; and more!

This issue of Surgical Oncology Clinics of North America, edited by Adam Berger, is devoted to Melanoma. Articles in this issue include: Current Staging and Prognostic Factors in Melanoma; Melanoma Pathology; Surgical Treatment of Primary and Recurrent Melanoma; Sentinel Lymph Node Mapping and Its Importance for Melanoma in the 21st Century; Lymph Node Dissection for Stage 3 Melanoma; Metastasectomy for Stage IV Melanoma; Local/Injectional Therapies for Satellite and In-Transit Disease; Regional Therapies for In-Transit Disease; Role for Radiation Therapy in Melanoma; Update on Immunotherapy for Melanoma; Targeted Therapies in Melanoma; and Evidence for Long-Term Follow-up of Melanoma Patients.

Non-melanoma skin cancer is a global public health issue. With an ever-increasing, and ageing, world population coupled with increasing numbers of immunosuppressed individuals the number of patients continues to rise. The head and neck is overwhelmingly the most frequent location for the development of a non-melanoma skin cancer and as such challenges the clinician with its complex anatomy. The importance of maintaining the aesthetics of the face and the function of the anatomy cannot be overstated, yet ultimately it is always the aim of curing a patient with the minimum of morbidity that clinicians strive for. However, the spectrum of presentations and subsequent management varies widely, ranging from patients with the ubiquitous low-risk mid-face basal cell carcinoma to those diagnosed with relatively uncommon but potentially life-threatening high-risk squamous cell carcinomas (e.g. involving metastatic lymph nodes or with perineural invasion present) and Merkel cell carcinomas.

In this issue of Dermatologic Clinics, guest editor Dr. Stan N. Tolkachjov brings his considerable expertise to Cutaneous Oncology Update. Top experts in the field cover key topics such as T-cell lymphomas; B-cell lymphomas; Mohs micrographic surgery; mesenchymal carcinomas; cutaneous oncology in the immunosuppressed; approaches to tumors of the nail unit and genitalia; and more. Contains 16 relevant, practice-oriented topics including squamous cell carcinoma (including high-risk); targeted therapy and immunotherapy in non-melanoma skin cancer; melanoma; targeted therapy and immunotherapy in melanoma; genetic expression profiles in cutaneous oncology; and more. Provides in-depth clinical reviews on cutaneous oncology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.